-
Nardino RJ. Chitosan for weight loss and cholesterol lowering. Altern Med Alert 2003;6(1):5-8.
-
Ramalanjaona G. Ginkgo biloba for memory enhancement: An update. Altern Med Alert 2003;6(1):1-5.
-
O'Mathuna DP. Anabolic-androgenic steroids for athletes: Adverse effects. Altern Med Alert 2003;6(1):8-11.
-
La Puma J. Coenzyme Q10 and Parkinson's disease. Altern Med Alert 2003;6(1):12.
-
Whether they want to lose a few pounds that were added over the holidays or develop a more comprehensive weight-loss goal, many of your patients will resolve to lose weight in the new year.
-
The 12-month results of CREDO (clopidogrel for the Reduction of Events During Observation) were presented at AHA to coincide with the publication of this important clinical trial in the November 20, 2002, issue of JAMA.
-
After years of legal wrangling, the FDA has approved loratadine (Claritin, Schering-Plough) as an over-the-counter (OTC) product for the treatment of seasonal rhinitis.
-
Carotid artery stenting is an attractive concept for the treatment of patients with significant carotid stenoses who were at higher risk for carotid endarterectomy, but stroke rates in initial studies were unacceptably high.
-
The pravastatin in elderly individuals at risk of vascular disease (PROSPER) trial is a study of statin therapy in high-risk elderly individuals. PROSPER tested the hypothesis that the benefits of statin therapy on cardiovascular disease, stroke, and cognitive decline would be seen in the elderly, which had not yet been rigorously investigated with respect to LDL lowering with a statin.
-
Iwai and colleagues evaluated the effects of adenosine in 42 patients who underwent an electrophysiologic study and radiofrequency ablation for recurrent atrial tachycardias.
